Search
for

    Sort by

    Research 16

    1. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases Frontiers in Pharmacology · 2021 · 21 citations
    2. Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study Frontiers in Pharmacology · 2026
    3. Identification of Candidate Genes for Min Pig Villi Hair Traits by Genome-Wide Association of Copy Number Variation Veterinary sciences · 2023 · 3 citations
    4. Azathioprine‐induced severe myelosuppression accompanied by massive hair loss and painful oral ulcer in an autoimmune hepatitis patient with <i>NUDT15</i> minor variant: A case report Clinical Case Reports · 2021 · 3 citations
    5. A Case of Azathioprine Induced Severe Myelosuppression and Alopecia Totalis in IgA Nephropathy Childhood Kidney Diseases · 2017
    6. CXXC5: A novel regulator and coordinator of TGF-β, BMP and Wnt signaling Journal of Cellular and Molecular Medicine · 2018 · 28 citations
    7. The vitamin B5/coenzyme A axis: A target for immunomodulation? European Journal of Immunology · 2024
    8. Systemic Lupus Erythematosus: What Every Clinician Needs to Know Mayo Clinic Proceedings · 2026
    9. COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists JEADV Clinical Practice · 2025
    10. NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease Journal of Gastroenterology · 2015 · 86 citations
    11. Molecular Mechanism of Avicennia marina (Forssk.) Vierh. in Inhibiting Hepatitis C Virus Based on Network Pharmacology and Molecular Docking Tropical Journal of Natural Product Research · 2025 · 1 citations
    12. The overview of the cosmetic exfoliants composition for keratosis pilaris skincare Repository of the University of Ljubljana (University of Ljubljana) · 2026
    13. NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders Journal of Medicinal Chemistry · 2025 · 45 citations
    14. Advancing Design Strategy of PROTACs for Cancer Therapy MedComm · 2025 · 4 citations
    15. Advances and Perspectives on Bioelectronic and Atomic Nanogenerators for Anticancer Therapy Nanoenergy Advances · 2025 · 2 citations
    16. Evolving CRBN ligands enhance the drug-like properties of protein degraders Journal of Enzyme Inhibition and Medicinal Chemistry · 2026